The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review
Surgical resection followed by concurrent radiation therapy and temozolomide (TMZ) chemotherapy is the current standard treatment for glioblastoma multiforme (GBM). The present metaanalysis investigated the impact of prolonged TMZ maintenance therapy (more than 6 cycles) in comparison with standard...
Main Authors: | Ehsan Alimohammadi, Seyed Reza Bagheri, Shahram Taheri, Maliheh Dayani, Alireza Abdi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-02-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://oncologyreviews.org/index.php/or/article/view/461 |
Similar Items
-
Evaluation of outcome and prognostic factors in patients of glioblastoma multiforme: A single institution experience
by: Narendra Kumar, et al.
Published: (2013-12-01) -
Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01) -
Clinical prognostic factors in newly diagnosed glioblastoma
by: Ionela Bizu, et al.
Published: (2019-06-01) -
Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review
by: Fateen Ata, et al.
Published: (2021-03-01) -
Hypofractionated Radiation Therapy with Temozolomide for Patients with Glioblastoma Multiforme Recursive Partitioning Analyzes Class V and VI
by: Fuzuli Tuğrul, et al.
Published: (2019-09-01)